PRTA 241220 40.00P (PRTA241220P40000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PRTA241220P40000

Watchlist

14.30
0.000.00%

15min DelayTrading Jan 25 11:48 ET

0.00High0.00Low

Intraday

5D
Daily

News

Top Premarket Decliners
MT NewswiresNov 19 07:39 ET
Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $62
Moomoo NewsNov 14 08:35 ET · Ratings
Prothena Corp Analyst Ratings
BenzingaNov 13 09:39 ET · Ratings
RBC Capital Maintains Prothena(PRTA.US) With Hold Rating, Maintains Target Price $24
Moomoo NewsNov 13 07:35 ET · Ratings
H.C. Wainwright Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $84
Moomoo NewsNov 13 06:36 ET · Ratings
JMP Securities Maintains Prothena(PRTA.US) With Buy Rating, Maintains Target Price $83
Moomoo NewsNov 13 01:32 ET · Ratings

Comments

Moomoo AI

Jan 31 05:38

Investors may miss opportunities or face setbacks if there's no rational basis for the P/S ratio. The moderate P/S ratio suggests investors anticipate a slowdown in revenue. Many investors, less bearish than analysts, hold onto their stocks, risking future disappointment if P/S aligns with growth outlook.

What Prothena Corporation Plc's (NASDAQ:PRTA) P/S Is Not Telling You

Moomoo AI

Nov 28, 2023 05:12

Analysts are forecasting that Prothena will reach break-even point before it might exhaust its cash runway. Given its impressive revenue growth and reduction in cash burn, Prothena appears well positioned to fund further growth with minimal shareholder dilution or borrowing.

We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth

Moomoo AI

Oct 30, 2023 07:14

Despite recent declines, the company's strong growth signals a potential investment opportunity. Market response to its revenue growth indicates interest despite lack of profits.

Prothena (NASDAQ:PRTA) Shareholders Are Still up 224% Over 3 Years Despite Pulling Back 15% in the Past Week

Moomoo AI

Oct 9, 2023 08:34

Overvaluation risk looms for Prothena's shares with high P/S ratio amid poor revenue and weak growth forecast. Investors may face disappointment if the share price realigns with the firm's bleak future outlook.

Prothena Corporation Plc's (NASDAQ:PRTA) Price Is Out Of Tune With Revenues

102098392 WY

Sep 28, 2022 12:18

$Prothena (PRTA.US)$. Up up up